Drug: FASLODEX Injury: Metastases to bone Quarter: 2016Q3
Total Records: 9 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125916191 | FASLODEX | Metastases to bone | ASTRAZENECA | 75.00 YR | F | 0 | 20160726 | US |
126202023 | FASLODEX | Metastases to bone | ASTRAZENECA | 60.00 YR | F | 0 | 20160921 | JP |
126271691 | FASLODEX | Metastases to bone | ASTRAZENECA | 636.00 MON | F | 0 | 20160805 | US |
127181811 | FASLODEX | Metastases to bone | ASTRAZENECA | 60.00 YR | F | 0 | 20160906 | US |
127560061 | FASLODEX | Metastases to bone | ASTRAZENECA | 70.00 YR | F | 0 | 20160916 | US |
127716941 | FASLODEX | Metastases to bone | NOVARTIS | 71.58 YR | F | 0 | 20160922 | US |
127846911 | FASLODEX | Metastases to bone | BAXTER | 61.32 YR | F | 0 | 20160927 | US |
127866991 | FASLODEX | Metastases to bone | ASTRAZENECA | 0.00 | F | 0 | 20160927 | US |
127870291 | FASLODEX | Metastases to bone | ASTRAZENECA | 61.00 YR | F | 0 | 20160927 | US |
Total Records: 9 Number of Pages: 1